Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
03 2022
Historique:
received: 25 09 2020
accepted: 13 12 2021
pubmed: 26 2 2022
medline: 28 4 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Brugada syndrome (BrS) is a cardiac arrhythmia disorder associated with sudden death in young adults. With the exception of SCN5A, encoding the cardiac sodium channel Na

Identifiants

pubmed: 35210625
doi: 10.1038/s41588-021-01007-6
pii: 10.1038/s41588-021-01007-6
pmc: PMC9376964
mid: NIHMS1817393
doi:

Substances chimiques

MAPRE2 protein, human 0
Microtubule-Associated Proteins 0
NAV1.5 Voltage-Gated Sodium Channel 0

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-239

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL047678
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139731
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG010464
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134328
Pays : United States
Organisme : NIGMS NIH HHS
ID : P50 GM115305
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL152201
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149826
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL105780
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL127704
Pays : United States
Organisme : Wellcome Trust
ID : 076113
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R56 HL138103
Pays : United States
Organisme : British Heart Foundation
ID : FS/11/71/28918
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL128914
Pays : United States
Organisme : Wellcome Trust
ID : 085475
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 090355
Pays : United Kingdom

Investigateurs

Konstantin Strauch (K)
Annette Peters (A)
Holger Schulz (H)
Lars Schwettmann (L)
Reiner Leidl (R)
Margit Heier (M)
Pascal Defaye (P)
Frédéric Anselme (F)
Jean Philippe Darmon (JP)
François Wiart (F)

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Brugada, P. & Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20, 1391–1396 (1992).
pubmed: 1309182 doi: 10.1016/0735-1097(92)90253-J
Priori, S. G. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 36, 2793–2867 (2015).
pubmed: 26320108 doi: 10.1093/eurheartj/ehv316
Chen, Q. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392, 293–296 (1998).
pubmed: 9521325 doi: 10.1038/32675
Le Scouarnec, S. et al. Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome. Hum. Mol. Genet. 24, 2757–2763 (2015).
pubmed: 25650408 doi: 10.1093/hmg/ddv036
Bezzina, C. R. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat. Genet. 45, 1044–1049 (2013).
pubmed: 23872634 pmcid: 3869788 doi: 10.1038/ng.2712
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).
pubmed: 20562875 pmcid: 3232052 doi: 10.1038/ng.608
Mizusawa, Y. & Wilde, A. A. M. Brugada syndrome. Circ. Arrhythm. Electrophysiol. 5, 606–616 (2012).
pubmed: 22715240 doi: 10.1161/CIRCEP.111.964577
van den Boogaard, M. et al. A common genetic variant within SCN10A modulates cardiac SCN5A expression. J. Clin. Invest. 124, 1844–1852 (2014).
pubmed: 24642470 pmcid: 3973109 doi: 10.1172/JCI73140
van Eif, V. W. W., Devalla, H. D., Boink, G. J. J. & Christoffels, V. M. Transcriptional regulation of the cardiac conduction system. Nat. Rev. Cardiol. 15, 617–630 (2018).
pubmed: 29875439 doi: 10.1038/s41569-018-0031-y
Gaborit, N. et al. Cooperative and antagonistic roles for Irx3 and Irx5 in cardiac morphogenesis and postnatal physiology. Development 139, 4007–4019 (2012).
pubmed: 22992950 pmcid: 3472592 doi: 10.1242/dev.081703
Shen, T. et al. Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. J. Clin. Invest. 121, 4640–4654 (2011).
pubmed: 22080862 pmcid: 3223071 doi: 10.1172/JCI59472
Veerman, C. C. et al. The Brugada syndrome susceptibility gene HEY2 modulates cardiac transmural ion channel patterning and electrical heterogeneity. Circ. Res. 121, 537–548 (2017).
pubmed: 28637782 doi: 10.1161/CIRCRESAHA.117.310959
Tarradas, A. et al. Transcriptional regulation of the sodium channel gene (SCN5A) by GATA4 in human heart. J. Mol. Cell. Cardiol. 102, 74–82 (2017).
pubmed: 27894866 doi: 10.1016/j.yjmcc.2016.10.013
Arnolds, D. E. et al. TBX5 drives Scn5a expression to regulate cardiac conduction system function. J. Clin. Invest. 122, 2509–2518 (2012).
pubmed: 22728936 pmcid: 3386825 doi: 10.1172/JCI62617
Braz, J. C. et al. PKC-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10, 248–254 (2004).
pubmed: 14966518 doi: 10.1038/nm1000
Goldspink, D. A. et al. The microtubule end-binding protein EB2 is a central regulator of microtubule reorganisation in apico-basal epithelial differentiation. J. Cell. Sci. 126, 4000–4014 (2013).
pubmed: 23813963
Ajima, R. et al. Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations. Genes Cells 13, 987–999 (2008).
pubmed: 18761673 doi: 10.1111/j.1365-2443.2008.01226.x
Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).
pubmed: 26854917 pmcid: 4767558 doi: 10.1038/ng.3506
GTEx Consortium et al.Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
pmcid: 5776756 doi: 10.1038/nature24277
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).
pubmed: 29632380 pmcid: 5896795 doi: 10.1038/s41588-018-0081-4
Iotchkova, V. et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 51, 343–353 (2019).
pubmed: 30692680 pmcid: 6908448 doi: 10.1038/s41588-018-0322-6
Gu, C. et al. The microtubule plus-end tracking protein EB1 is required for Kv1 voltage-gated K
pubmed: 17145502 doi: 10.1016/j.neuron.2006.10.022
Wilde, A. A. M. et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J. Mol. Cell. Cardiol. 49, 543–553 (2010).
pubmed: 20659475 pmcid: 2932806 doi: 10.1016/j.yjmcc.2010.07.012
Talmud, P. J. et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 381, 1293–1301 (2013).
pubmed: 23433573 doi: 10.1016/S0140-6736(12)62127-8
Lahrouchi, N. et al. Transethnic genome-wide association study provides insights in the genetic architecture and heritability of long QT syndrome. Circulation 142, 324–338 (2020).
pubmed: 32429735 pmcid: 7382531 doi: 10.1161/CIRCULATIONAHA.120.045956
Sotoodehnia, N. et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat. Genet. 42, 1068–1076 (2010).
pubmed: 21076409 pmcid: 3338195 doi: 10.1038/ng.716
van Setten, J. et al. PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity. Nat. Commun. 9, 2904 (2018).
pubmed: 30046033 pmcid: 6060178 doi: 10.1038/s41467-018-04766-9
Arking, D. E. et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat. Genet. 46, 826–836 (2014).
pubmed: 24952745 pmcid: 4124521 doi: 10.1038/ng.3014
Roselli, C. et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet. 50, 1225–1233 (2018).
pubmed: 29892015 pmcid: 6136836 doi: 10.1038/s41588-018-0133-9
Nielsen, J. B. et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat. Genet. 50, 1234–1239 (2018).
pubmed: 30061737 pmcid: 6530775 doi: 10.1038/s41588-018-0171-3
Rivaud, M. R. et al. A common co-morbidity modulates disease expression and treatment efficacy in inherited cardiac sodium channelopathy. Eur. Heart J. 39, 2898–2907 (2018).
pubmed: 29718149 doi: 10.1093/eurheartj/ehy247
Priori, S. G. et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15, 1389–1406 (2013).
pubmed: 23994779 doi: 10.1093/europace/eut272
Al-Khatib, S. M. et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 138, e210–e271 (2018).
pubmed: 29084733
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–423 (2015).
pubmed: 25741868 pmcid: 4544753 doi: 10.1038/gim.2015.30
Whiffin, N. et al. CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation. Genet. Med. 20, 1246–1254 (2018).
pubmed: 29369293 pmcid: 6558251 doi: 10.1038/gim.2017.258
Kapplinger, J. D. et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 7, 33–46 (2010).
pubmed: 20129283 doi: 10.1016/j.hrthm.2009.09.069
Walsh, R., Peters, N. S., Cook, S. A. & Ware, J. S. Paralogue annotation identifies novel pathogenic variants in patients with Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. J. Med. Genet. 51, 35–44 (2014).
pubmed: 24136861 doi: 10.1136/jmedgenet-2013-101917
Denham, N. C. et al. Systematic re-evaluation of SCN5A variants associated with Brugada syndrome. J. Cardiovasc. Electrophysiol. 30, 118–127 (2019).
pubmed: 30203441 doi: 10.1111/jce.13740
Walsh, R. et al. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of HCM. Genome Med. 11, 5 (2019).
pubmed: 30696458 pmcid: 6350371 doi: 10.1186/s13073-019-0616-z
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836 doi: 10.1038/ng.3656
Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).
pubmed: 20562875 pmcid: 3232052 doi: 10.1038/ng.608
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363 doi: 10.1016/j.ajhg.2010.11.011
Lee, S. H., Wray, N. R., Goddard, M. E. & Visscher, P. M. Estimating missing heritability for disease from genome-wide association studies. Am. J. Hum. Genet. 88, 294–305 (2011).
pubmed: 21376301 pmcid: 3059431 doi: 10.1016/j.ajhg.2011.02.002
Vutthikraivit, W. et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis. Acta Cardiol. Sin. 34, 267–277 (2018).
pubmed: 29844648 pmcid: 5968343
Machiela, M. J. & Chanock, S. J. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31, 3555–3557 (2015).
pubmed: 26139635 pmcid: 4626747 doi: 10.1093/bioinformatics/btv402
Hormozdiari, F. et al. Colocalization of GWAS and eQTL signals detects target genes. Am. J. Hum. Genet. 99, 1245–1260 (2016).
pubmed: 27866706 pmcid: 5142122 doi: 10.1016/j.ajhg.2016.10.003
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5
Schmitt, A. D. et al. A compendium of chromatin contact maps reveals spatially active regions in the human genome. Cell Rep. 17, 2042–2059 (2016).
pubmed: 27851967 pmcid: 5478386 doi: 10.1016/j.celrep.2016.10.061
Pers, T. H., Timshel, P. & Hirschhorn, J. N. SNPsnap: a Web-based tool for identification and annotation of matched SNPs. Bioinformatics 31, 418–420 (2015).
pubmed: 25316677 doi: 10.1093/bioinformatics/btu655
Leeuw, C. A., de, Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
pubmed: 16199517 pmcid: 1239896 doi: 10.1073/pnas.0506580102
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285 doi: 10.1038/ng.3404
Backenroth, D. et al. FUN-LDA: a latent dirichlet allocation model for predicting tissue-specific functional effects of noncoding variation: methods and applications. Am. J. Hum. Genet. 102, 920–942 (2018).
pubmed: 29727691 pmcid: 5986983 doi: 10.1016/j.ajhg.2018.03.026
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887 doi: 10.1093/bioinformatics/btq340
Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465 doi: 10.1371/journal.pmed.1001779
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Aragam, K. G. et al. Phenotypic refinement of heart failure in a national biobank facilitates genetic discovery. Circulation http://dx.doi.org/CIRCULATIONAHA.118.035774 (2018).
Choi, S. H. et al. Monogenic and polygenic contributions to atrial fibrillation risk: results from a national biobank. Circ. Res. 126, 200–209 (2020).
pubmed: 31691645 doi: 10.1161/CIRCRESAHA.119.315686
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Panáková, D., Werdich, A. A. & Macrae, C. A. Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca(2+) channel. Nature 466, 874–878 (2010).
pubmed: 20657579 pmcid: 2921013 doi: 10.1038/nature09249
Kuo, H.-H. et al. Negligible-cost and weekend-free chemically defined human iPSC culture. Stem Cell Rep. 14, 256–270 (2020).
doi: 10.1016/j.stemcr.2019.12.007
Burridge, P. W., Holmström, A. & Wu, J. C. Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells. Curr. Protoc. Hum. Genet. 87, 21.3.1–21.3.15 (2015).
Burridge, P. W. et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 11, 855–860 (2014).
pubmed: 24930130 pmcid: 4169698 doi: 10.1038/nmeth.2999
Veerman, C. C. et al. Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem? Stem Cells Dev. 24, 1035–1052 (2015).
pubmed: 25583389 doi: 10.1089/scd.2014.0533
Barry, P. H. & Lynch, J. W. Liquid junction potentials and small cell effects in patch-clamp analysis. J. Membr. Biol. 121, 101–117 (1991).
pubmed: 1715403 doi: 10.1007/BF01870526
Bravo, E. et al. Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA). BMC Med. 13, 33 (2015).
pubmed: 25855867 pmcid: 4331335 doi: 10.1186/s12916-015-0266-y
Wang, Y. et al. The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 19, 151 (2018).
pubmed: 30286773 pmcid: 6172833 doi: 10.1186/s13059-018-1519-9

Auteurs

Julien Barc (J)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France. julien.barc@univ-nantes.fr.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart, . julien.barc@univ-nantes.fr.

Rafik Tadros (R)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Medicine, Cardiovascular Genetics Center, Montreal Heart Institute and Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Charlotte Glinge (C)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

David Y Chiang (DY)

Medicine, Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Mariam Jouni (M)

Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Floriane Simonet (F)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Sean J Jurgens (SJ)

The Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Manon Baudic (M)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Michele Nicastro (M)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Franck Potet (F)

Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Joost A Offerhaus (JA)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Roddy Walsh (R)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Seung Hoan Choi (SH)

The Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Arie O Verkerk (AO)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Department of Medical Biology, University of Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Yuka Mizusawa (Y)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Soraya Anys (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Damien Minois (D)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Marine Arnaud (M)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Josselin Duchateau (J)

IHU Liryc, Electrophysiology and Heart Modeling Institute, fondation Bordeaux Université, Pessac-Bordeaux, France.
Université Bordeaux, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
INSERM, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France.

Yanushi D Wijeyeratne (YD)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, UK.
Cardiology Clinical Academic Group, St. George's University Hospitals' NHS Foundation Trust, London, UK.

Alison Muir (A)

Cardiology, Belfast Health and Social Care Trust and Queen's University Belfast, Belfast, UK.

Michael Papadakis (M)

Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, UK.
Cardiology Clinical Academic Group, St. George's University Hospitals' NHS Foundation Trust, London, UK.

Silvia Castelletti (S)

Center for Cardiac Arrhythmias of Genetic Origin, Istituto Auxologico Italiano IRCCS, Milan, Italy.

Margherita Torchio (M)

Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.

Cristina Gil Ortuño (CG)

Cardiogenetic, Unidad de Cardiopatías Familiares, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, Murcia, Spain.

Javier Lacunza (J)

Cardiology, Unidad de Cardiopatías Familiares, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain.

Daniela F Giachino (DF)

Clinical and Biological Sciences, Medical Genetics, University of Torino, Orbassano, Italy.
Medical Genetics, San Luigi Gonzaga University Hospital, Orbassano, Italy.

Natascia Cerrato (N)

Medical Sciences, Cardiology, University of Torino, Torino, Italy.

Raphaël P Martins (RP)

Cardiologie et Maladies vasculaires, Université Rennes1 - CHU Rennes, Rennes, France.

Oscar Campuzano (O)

Cardiovascular Genetics Center, University of Girona-IDIBGI, Girona, Spain.
Medical Science Department, University of Girona, Girona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Biochemistry and Molecular Genetics Department, Hospital Clinic, University of Barcelona-IDIBAPS, Barcelona, Spain.

Sonia Van Dooren (S)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Centre for Medical Genetics, research group Reproduction and Genetics, research cluster Reproduction, Genetics and Regenerative Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Aurélie Thollet (A)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Florence Kyndt (F)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Andrea Mazzanti (A)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Molecular Cardiology, ICS Maugeri, IRCCS and Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Nicolas Clémenty (N)

Department of Cardiology, CHU Tours, Tours, France.

Arnaud Bisson (A)

Department of Cardiology, CHU Tours, Tours, France.

Anniek Corveleyn (A)

Department of Human Genetics, Catholic University Leuven, Leuven, Belgium.

Birgit Stallmeyer (B)

University Hospital Münster, Institute for Genetics of Heart Diseases (IfGH), Münster, Germany.

Sven Dittmann (S)

University Hospital Münster, Institute for Genetics of Heart Diseases (IfGH), Münster, Germany.

Johan Saenen (J)

Cardiology, Electrophysiology - Cardiogenetics, University of Antwerp/Antwerp University Hospital, Edegem, Belgium.

Antoine Noël (A)

Department of Cardiology, University Hospital of Brest, Brest, France.

Shohreh Honarbakhsh (S)

Cardiology, Medicine, Barts Heart Centre, London, UK.

Boris Rudic (B)

Department 1st of Medicine, Cardiology, University Medical Center Mannheim, Mannheim, Germany.
German Center for Cardiovascular Research (DZHK), Mannheim, Germany.

Halim Marzak (H)

Department of Cardiology, University Hospital of Strasbourg, Strasbourg, France.

Matthew K Rowe (MK)

Medicine, Cardiology, Western University, London, Ontario, Canada.

Claire Federspiel (C)

Department of Cardiovascular Medicine, Vendée Hospital, Service de Cardiologie, La Roche sur Yon, France.

Sophie Le Page (S)

Service de cardiologie, CHU Angers, Angers, France.

Leslie Placide (L)

Department of Cardiology, CHU Montpellier, Montpellier, France.

Antoine Milhem (A)

Department of Cardiology, CH La Rochelle, La Rochelle, France.

Hector Barajas-Martinez (H)

Lankenau Institute for Medical Research, Wynnewood, PA, USA.

Britt-Maria Beckmann (BM)

Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
University Hospital of the Johann Wolfgang Goethe University Frankfurt, Institute of Legal Medicine, Frankfurt, Germany.

Ingrid P Krapels (IP)

Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.

Johannes Steinfurt (J)

Department of Cardiology and Angiology I, Heart Center, University Freiburg, Freiburg, Germany.

Bo Gregers Winkel (BG)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Reza Jabbari (R)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Moore B Shoemaker (MB)

Medicine, Cardiology, Vanderbilt University Medical Center, Nashville, TN, USA.

Bas J Boukens (BJ)

Department of Medical Biology, University of Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Doris Škorić-Milosavljević (D)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Hennie Bikker (H)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Genome Diagnostics Laboratory, Clinical Genetics, Amsterdam UMC, Amsterdam, The Netherlands.

Federico Manevy (F)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Peter Lichtner (P)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Marta Ribasés (M)

Psychiatric Genetics Unit, Institute Vall d'Hebron Research (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Thomas Meitinger (T)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Martina Müller-Nurasyid (M)

Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
IBE, LMU Munich, Munich, Germany.
Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Department of Internal Medicine I (Cardiology), Hospital of the Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.

Jan H Veldink (JH)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Leonard H van den Berg (LH)

Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Philip Van Damme (P)

Neurology Department University Hospital Leuven, Neuroscience Department KU Leuven, Center for Brain & Disease Research VIB, Leuven, Belgium.

Daniele Cusi (D)

Scientific Unit, Bio4Dreams - Business Nursery for Life Sciences, Milan, Italy.

Chiara Lanzani (C)

Nephrology, Genomics of Renal Diseases and Hypertension Unit, Università Vita Salute San Raffaele, Milan, Italy.

Sidwell Rigade (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Eric Charpentier (E)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
Université de Nantes, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes, France.

Estelle Baron (E)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Stéphanie Bonnaud (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
Université de Nantes, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes, France.

Simon Lecointe (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Audrey Donnart (A)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
Université de Nantes, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, CNRS UMS 3556, Nantes, France.

Hervé Le Marec (H)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Stéphanie Chatel (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Matilde Karakachoff (M)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Stéphane Bézieau (S)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Barry London (B)

Department of Internal Medicine, Division of Cardiovascular Medicine, Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, IA, USA.

Jacob Tfelt-Hansen (J)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Department of Forensic Medicine, University of Copenhagen, Copenhagen, Denmark.

Dan Roden (D)

Medicine, Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Medicine, Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Medicine, Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.

Katja E Odening (KE)

Department of Cardiology and Angiology I, Heart Center, University Freiburg, Freiburg, Germany.
Department of Cardiology, Translational Cardiology, University Hospital Bern, Bern, Switzerland.

Marina Cerrone (M)

Medicine, Leon H. Charney Division of Cardiology, Heart Rhythm Center and Cardiovascular Genetics Program, New York University School of Medicine, New York, NY, USA.

Larry A Chinitz (LA)

Medicine, Leon H. Charney Division of Cardiology, Heart Rhythm Center and Cardiovascular Genetics Program, New York University School of Medicine, New York, NY, USA.

Paul G Volders (PG)

Department of Cardiology, CARIM, Maastricht University Medical Center, Maastricht, The Netherlands.

Maarten P van de Berg (MP)

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Gabriel Laurent (G)

Cardiology Department, ImVia lab team IFTIM, University Hospital Dijon, Dijon, France.

Laurence Faivre (L)

Centre de Génétique, FHU TRANSLAD, Dijon, France.

Charles Antzelevitch (C)

Lankenau Institute for Medical Research, Wynnewood, PA, USA.

Stefan Kääb (S)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.
German Center for Cardiovascular Research (DZHK), Partnersite Munich, Munich, Germany.

Alain Al Arnaout (AA)

Department of Cardiology, CH La Rochelle, La Rochelle, France.

Jean-Marc Dupuis (JM)

Service de cardiologie, CHU Angers, Angers, France.

Jean-Luc Pasquie (JL)

Department of Cardiology, CNRS UMR9214 - Inserm U1046 - PHYMEDEXP, Université de Montpellier et CHU Montpellier, Montpellier, France.

Olivier Billon (O)

Department of Cardiovascular Medicine, Vendée Hospital, Service de Cardiologie, La Roche sur Yon, France.

Jason D Roberts (JD)

Medicine, Cardiology, Western University, London, Ontario, Canada.

Laurence Jesel (L)

Department of Cardiology, University Hospital of Strasbourg, Strasbourg, France.
INSERM 1260 - Regenerative Nanomedecine, University of Strasbourg, Strasbourg, France.

Martin Borggrefe (M)

Department 1st of Medicine, Cardiology, University Medical Center Mannheim, Mannheim, Germany.
German Center for Cardiovascular Research (DZHK), Mannheim, Germany.

Pier D Lambiase (PD)

Cardiology, Medicine, Barts Heart Centre, London, UK.
Institute of Cardiovasculr Science, UCL, Population Health, UCL, London, UK.

Jacques Mansourati (J)

Department of Cardiology, University Hospital of Brest, Brest, France.

Bart Loeys (B)

Center for Medical Genetics, Cardiogenetics, University of Antwerp/Antwerp University Hospital, Edegem, Belgium.

Antoine Leenhardt (A)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Cardiology, Hopital Bichat, Paris, France.

Pascale Guicheney (P)

Sorbonne Université, Paris, France.
UMR_S1166, Faculté de médecine, Sorbonne Université, INSERM, Paris, France.

Philippe Maury (P)

Service de cardiologie, Hôpital Rangueil, CHU de Toulouse, Toulouse, France.

Eric Schulze-Bahr (E)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
University Hospital Münster, Institute for Genetics of Heart Diseases (IfGH), Münster, Germany.

Tomas Robyns (T)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.
Cardiovascular Sciences, University of Leuven, Leuven, Belgium.

Jeroen Breckpot (J)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Human Genetics, Catholic University Leuven, Leuven, Belgium.

Dominique Babuty (D)

Department of Cardiology, CHU Tours, Tours, France.

Silvia G Priori (SG)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Molecular Cardiology, ICS Maugeri, IRCCS and Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Carlo Napolitano (C)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Molecular Cardiology, ICS Maugeri, IRCCS and Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Carlo de Asmundis (C)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Heart Rhythm Management Center, Postgraduate Program in Cardiac Electrophysiology and Pacing Universitair Ziekenhuis, Brussel-Vrije Universiteit Brussel, ERN Heart Guard Center, Brussels, Belgium.
IDIBAPS, Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Pedro Brugada (P)

Heart Rhythm Management Center, UZ Brussel-VUB, Brussels, Belgium.

Ramon Brugada (R)

Hospital Trueta, CiberCV, University of Girona, IDIBGI, Girona, Spain, Barcelona, Spain.

Elena Arbelo (E)

Arrhythmia Section, Cardiology Department, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.

Josep Brugada (J)

Cardiovascular Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.

Philippe Mabo (P)

Cardiologie et Maladies vasculaires, Université Rennes1 - CHU Rennes, Rennes, France.

Nathalie Behar (N)

Cardiologie et Maladies vasculaires, Université Rennes1 - CHU Rennes, Rennes, France.

Carla Giustetto (C)

Medical Sciences, Cardiology, University of Torino, Torino, Italy.

Maria Sabater Molina (MS)

Cardiogenetic, Unidad de Cardiopatías Familiares, Instituto Murciano de Investigación Biosanitaria, Universidad de Murcia, Murcia, Spain.

Juan R Gimeno (JR)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Cardiology, Unidad de Cardiopatías Familiares, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain.

Can Hasdemir (C)

Department of Cardiology, Ege University School of Medicine, Bornova, Turkey.

Peter J Schwartz (PJ)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Center for Cardiac Arrhythmias of Genetic Origin, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.

Lia Crotti (L)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Center for Cardiac Arrhythmias of Genetic Origin, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Laboratory of Cardiovascular Genetics, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.
Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Istituto Auxologico Italiano IRCCS, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Pascal P McKeown (PP)

Cardiology, Belfast Health and Social Care Trust and Queen's University Belfast, Belfast, UK.

Sanjay Sharma (S)

Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, UK.
Cardiology Clinical Academic Group, St. George's University Hospitals' NHS Foundation Trust, London, UK.

Elijah R Behr (ER)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Molecular and Clinical Sciences Research Institute, St. George's, University of London, London, UK.
Cardiology Clinical Academic Group, St. George's University Hospitals' NHS Foundation Trust, London, UK.

Michel Haissaguerre (M)

IHU Liryc, Electrophysiology and Heart Modeling Institute, fondation Bordeaux Université, Pessac-Bordeaux, France.
Université Bordeaux, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
INSERM, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France.

Frédéric Sacher (F)

IHU Liryc, Electrophysiology and Heart Modeling Institute, fondation Bordeaux Université, Pessac-Bordeaux, France.
Université Bordeaux, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
INSERM, Centre de recherche Cardio-Thoracique de Bordeaux, Bordeaux, France.
Electrophysiology and Ablation Unit, Bordeaux University Hospital (CHU), Pessac, France.

Caroline Rooryck (C)

CHU Bordeaux, Service de Génétique Médicale, Bordeaux, France.
Université de Bordeaux, Maladies Rares: Génétique et Métabolisme (MRGM), INSERM U1211, Bordeaux, France.

Hanno L Tan (HL)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Netherlands Heart Institute, Utrecht, The Netherlands.

Carol A Remme (CA)

Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Pieter G Postema (PG)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Mario Delmar (M)

Medicine, Cardiology, New York University School of Medicine, New York, NY, USA.

Patrick T Ellinor (PT)

Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital and Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Boston, MA, USA.

Steven A Lubitz (SA)

Cardiac Arrhythmia Service and Cardiovascular Research Center, Massachusetts General Hospital and Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Boston, MA, USA.

Jean-Baptiste Gourraud (JB)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.

Michael W Tanck (MW)

Clinical Epidemiology, Biostatistics and Bioinformatics, Clinical Methods and Public Health, Amsterdam Public Health, Amsterdam, The Netherlands.

Alfred L George (AL)

Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Calum A MacRae (CA)

Medicine, Cardiovascular Medicine, Genetics and Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Paul W Burridge (PW)

Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Christian Dina (C)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.

Vincent Probst (V)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.

Arthur A Wilde (AA)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.
Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Jean-Jacques Schott (JJ)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.

Richard Redon (R)

Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart.

Connie R Bezzina (CR)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart: ERN GUARD-Heart, . c.r.bezzina@amsterdamumc.nl.
Department of Clinical and Experimental Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. c.r.bezzina@amsterdamumc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH